
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
CONTRAD SWISS is a dynamic Swiss-based pharmaceutical corporation revolutionizing the regenerative medicine landscape. Headquartered in Lugano, Contrad Swiss is the owner of proprietary SIGMOLECS Technology which takes the current use of peptides as active ingredients a giant step forward. The company portfolio comprises medical devices and aesthetic products, positioned in the premium segment, delivering unparalleled value. SIGMOLECS is a unique technology guiding cell behaviour for a wide range of treatments. It talks to cells in their own language, enabling more effective therapies. It is designed to work with various treatment methods, following the bodys natural systems and also enhancing the...
Cosmetica,biotecnologie,nutraceutica,dispositivi medici,ortopedica,dermatologia,trattemento del dolore,and medicina rigenerativa
Contrad swiss operates in the Pharmaceutical manufacturing industry.
Contrad swiss's revenue is 11m - 100m
Contrad swiss has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.